Further adjusting for baseline high-sensitivity C-reactive protein level (for glucose abnormality: adjusted HR, 2.36; 95% CI, 1.52-3.68; for high BP: adjusted HR, 1.65; 95% CI, 1.12,-2.44) and HOMA insulin resistance index (for glucose abnormality: adjusted HR, 2.58; 95% CI, 1.65-4.04; for high BP: adjusted HR, 1.83; 95% CI, 1.23-2.71), the association between MHO and abnormalities of glucose and BP did not change (Table 2). The gene discussed is CRP; the disease is Insulin resistance.